00911.HK
Qianhai Health Holdings Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 0.32
+0.00%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -29.9%
- EBITDA
- -56.0%
- EBIT
- -59.3%
- Net income
- +353.2%
- EPS
- +355.8%
- Free cash flow
- +572.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026